{"schema_version":"secwatch.filing_event.v1","accession":"0001785530-24-000026","form_type":"8-K","ticker":"HOWL","cik":"0001785530","company_name":"Werewolf Therapeutics, Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.519322+00:00","generated_at":"2026-05-31T11:07:17.343029+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Werewolf Therapeutics Q2 2024 net loss $17.2M; positive clinical data for WTX-124 and WTX-330","bullets":["Net loss of $17.2M in Q2 2024 vs $5.1M in Q2 2023; R&D expenses rose to $15.3M from $9.6M.","Cash and equivalents $135.3M at June 30, 2024; sufficient to fund operations through at least Q1 2026.","WTX-124 monotherapy achieved 3 objective responses, including 1 complete response at 18 mg IV Q2W RDE.","WTX-330 showed 1 unconfirmed partial response in melanoma; therapeutically relevant exposure levels achieved.","Updated WTX-124 combination data and expansion arms expected H2 2024; WTX-330 data in Q4 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001785530-24-000026","json":"https://secwatch.observer/filing/0001785530-24-000026.json","markdown":"https://secwatch.observer/filing/0001785530-24-000026.md","text":"https://secwatch.observer/filing/0001785530-24-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785530/000178553024000026/0001785530-24-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785530/000178553024000026/howl-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:07:17.343029+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}